These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1279828)

  • 41. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
    Rodionov AP; Lyskovtsev VV; Ignatova NA; Tolmacheva EA; Grigor'eva EK; Belinskiaia GF; Sheĭnberg BV
    Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stimulation technics in the evaluation of the antiarrhythmic effect of a drug at the ventricular level].
    Levy S
    Therapie; 1986; 41(2):103-6. PubMed ID: 2425446
    [No Abstract]   [Full Text] [Related]  

  • 43. Premature ventricular complexes and ventricular tachycardia: long-term perspective for prognosis and treatment.
    Anderson JL
    Trans Assoc Life Insur Med Dir Am; 1988; 71():27-35. PubMed ID: 2453094
    [No Abstract]   [Full Text] [Related]  

  • 44. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor based on the data from an acute drug test].
    Smerdina IS; Fomichev VI; Nesvetov VN; Gorshkov VA; Preobrazhenskiĭ DV
    Kardiologiia; 1993; 33(7):11-4, 3. PubMed ID: 8309173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anti-arrhythmic effect of competitive aldosterone antagonists].
    Merzon AK; Khorunzhaia LV; Doviner AD; Berezov VM
    Vrach Delo; 1984 Apr; (4):18-22. PubMed ID: 6204456
    [No Abstract]   [Full Text] [Related]  

  • 47. Adenosine-Responsive wide QRS complex tachycardia: what is the mechanism?
    Oral H; Michaud GF; Morady F
    J Cardiovasc Electrophysiol; 1999 Dec; 10(12):1688-9. PubMed ID: 10636199
    [No Abstract]   [Full Text] [Related]  

  • 48. Wide complex tachycardia and adenosine.
    Schuller JL; Varosy PD; Nguyen DT
    JAMA Intern Med; 2013 Sep; 173(17):1644-6. PubMed ID: 23897223
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of prolonged ethmozine treatment in patients with ventricular arrhythmias].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1983 Nov; 23(11):51-5. PubMed ID: 6197557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].
    Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447
    [No Abstract]   [Full Text] [Related]  

  • 51. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F; Torzillo D; Sandrone G; Dalla Vecchia L; Cappiello E
    Eur Heart J; 1992 Nov; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of combinations of group I anti-arrhythmia drugs in patients with refractory arrhythmias].
    Abdalla A; Mazur NA; Ivanova LA; Sumarokov AV
    Kardiologiia; 1988 Feb; 28(2):42-6. PubMed ID: 2453699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of oral pentisomide on ECG and hemodynamics].
    Ni Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Dec; 18(6):365-7. PubMed ID: 2093559
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antiarrhythmic effect and electrophysiologic study of berberine].
    Zhao XZ; Guo X
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun; 17(3):159-61. PubMed ID: 2480875
    [No Abstract]   [Full Text] [Related]  

  • 55. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
    Skibitskiĭ VV
    Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
    [No Abstract]   [Full Text] [Related]  

  • 56. Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Farouque HM; Sanders P; Young GD
    Am J Cardiol; 2000 Dec; 86(11):1270-2, A9. PubMed ID: 11090808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A method for the individual choice of anti-arrhythmia preparations in extrasystole].
    Lipnitskiĭ TN; Denisiuk VI; Kolesnik PF; Muravitskiĭ OV; Sizova MP
    Lik Sprava; 1992 Jun; (6):74-6. PubMed ID: 1280888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia.
    Anderson JL; Reddy CP; Myerburg RJ; Waxman HL; de Vane PJ
    Am J Cardiol; 1993 Mar; 71(8):686-94. PubMed ID: 8447266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of K+ and Mg2+ in treatment of acute myocardial infarct].
    Kunert M; Scheuble L; Stolzenburg H; Gülker H
    Herz; 1997 Jun; 22 Suppl 1():63-72. PubMed ID: 9333594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacodynamics of allapinine during long-term infusion in patients with chronic ischemic heart disease and frequent ventricular extrasystole].
    Khakimov AG; Merkulova IN; Semeĭkin OV; Frolova EP; Mansurova GL; Mazaev AV; Ruda MIa
    Kardiologiia; 1991 Nov; 31(11):58-62. PubMed ID: 1725191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.